COVID-19 Impact on Global Human Somatotropin, Market Insights and Forecast to 2026

Publisher Name :
Date: 29-Jun-2020
No. of pages: 117
Inquire Before Buying

Human Somatotropin market is segmented 2, and 7. Players, stakeholders, and other participants in the global Human Somatotropin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast 2 and 7 for the period 2015-2026.

Segment 2, the Human Somatotropin market is segmented into

- Powder

- Solvent

Segment 7, the Human Somatotropin market is segmented into

- Growth Hormone Deficiency (GHD)

- Turner Syndrome

- Chronic Renal Insufficiency

- Prader Willi Syndrome

- Small for Gestational Age

- SHOX Deficiency

- Others

Regional and Country-level Analysis

The Human Somatotropin market is analysed and market size information is provided by regions (countries).

The key regions covered in the Human Somatotropin market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, United States, Canada, Germany, France, UK, Italy, Russia, China, Japan, South Korea, India, Australia, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Brazil, Turkey, GCC Countries, Egypt, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast 2, and 7 segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Human Somatotropin Market Share Analysis

Human Somatotropin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Human Somatotropin business, the date to enter into the Human Somatotropin market, Human Somatotropin product introduction, recent developments, etc.

The major vendors covered:

- Novo Nordisk

- Pfizer

- Eli Lilly

- Merck Serono

- F. Hoffmann-La Roche

- Ferring Pharmaceuticals

- GeneScience Pharmaceuticals

- Ipsen

- LG Life Sciences

- Sandoz International

- Anhui Anke Biotechnology

COVID-19 Impact on Global Human Somatotropin, Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Human Somatotropin Product Introduction
1.2 Market Segments
1.3 Key Human Somatotropin Manufacturers Covered: Ranking by Revenue
1.4 Market 2
1.4.1 Global Human Somatotropin Market Size Growth Rate 2
1.4.2 Powder
1.4.3 Solvent
1.5 Market 7
1.5.1 Global Human Somatotropin Market Size Growth Rate 7
1.5.2 Growth Hormone Deficiency (GHD)
1.5.3 Turner Syndrome
1.5.4 Chronic Renal Insufficiency
1.5.5 Prader Willi Syndrome
1.5.6 Small for Gestational Age
1.5.7 SHOX Deficiency
1.5.8 Others
1.6 Coronavirus Disease 2019 (Covid-19): Human Somatotropin Industry Impact
1.6.1 How the Covid-19 is Affecting the Human Somatotropin Industry
1.6.1.1 Human Somatotropin Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Human Somatotropin Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Human Somatotropin Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Human Somatotropin Market Size Estimates and Forecasts
2.1.1 Global Human Somatotropin Revenue 2015-2026
2.1.2 Global Human Somatotropin Sales 2015-2026
2.2 Human Somatotropin Market Size by Region: 2020 Versus 2026
2.2.1 Global Human Somatotropin Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Human Somatotropin Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Human Somatotropin Competitor Landscape by Players
3.1 Human Somatotropin Sales by Manufacturers
3.1.1 Human Somatotropin Sales by Manufacturers (2015-2020)
3.1.2 Human Somatotropin Sales Market Share by Manufacturers (2015-2020)
3.2 Human Somatotropin Revenue by Manufacturers
3.2.1 Human Somatotropin Revenue by Manufacturers (2015-2020)
3.2.2 Human Somatotropin Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Human Somatotropin Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Human Somatotropin Revenue in 2019
3.2.5 Global Human Somatotropin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Human Somatotropin Price by Manufacturers
3.4 Human Somatotropin Manufacturing Base Distribution, Product Types
3.4.1 Human Somatotropin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human Somatotropin Product Type
3.4.3 Date of International Manufacturers Enter into Human Somatotropin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data 2 (2015-2026)
4.1 Global Human Somatotropin Market Size 2 (2015-2020)
4.1.1 Global Human Somatotropin Sales 2 (2015-2020)
4.1.2 Global Human Somatotropin Revenue 2 (2015-2020)
4.1.3 Human Somatotropin Average Selling Price (ASP) 2 (2015-2026)
4.2 Global Human Somatotropin Market Size Forecast 2 (2021-2026)
4.2.1 Global Human Somatotropin Sales Forecast 2 (2021-2026)
4.2.2 Global Human Somatotropin Revenue Forecast 2 (2021-2026)
4.2.3 Human Somatotropin Average Selling Price (ASP) Forecast 2 (2021-2026)
4.3 Global Human Somatotropin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data 7 (2015-2026)
5.1 Global Human Somatotropin Market Size 7 (2015-2020)
5.1.1 Global Human Somatotropin Sales 7 (2015-2020)
5.1.2 Global Human Somatotropin Revenue 7 (2015-2020)
5.1.3 Human Somatotropin Price 7 (2015-2020)
5.2 Human Somatotropin Market Size Forecast 7 (2021-2026)
5.2.1 Global Human Somatotropin Sales Forecast 7 (2021-2026)
5.2.2 Global Human Somatotropin Revenue Forecast 7 (2021-2026)
5.2.3 Global Human Somatotropin Price Forecast 7 (2021-2026)
6 North America
6.1 North America Human Somatotropin by Country
6.1.1 North America Human Somatotropin Sales by Country
6.1.2 North America Human Somatotropin Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Human Somatotropin Market Facts & Figures 2
6.3 North America Human Somatotropin Market Facts & Figures 7
7 Europe
7.1 Europe Human Somatotropin by Country
7.1.1 Europe Human Somatotropin Sales by Country
7.1.2 Europe Human Somatotropin Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Human Somatotropin Market Facts & Figures 2
7.3 Europe Human Somatotropin Market Facts & Figures 7
8 Asia Pacific
8.1 Asia Pacific Human Somatotropin by Region
8.1.1 Asia Pacific Human Somatotropin Sales by Region
8.1.2 Asia Pacific Human Somatotropin Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Thailand
8.1.10 Malaysia
8.1.11 Philippines
8.1.12 Vietnam
8.2 Asia Pacific Human Somatotropin Market Facts & Figures 2
8.3 Asia Pacific Human Somatotropin Market Facts & Figures 7
9 Latin America
9.1 Latin America Human Somatotropin by Country
9.1.1 Latin America Human Somatotropin Sales by Country
9.1.2 Latin America Human Somatotropin Revenue by Country
9.1.3 Brazil
9.2 Central & South America Human Somatotropin Market Facts & Figures 2
9.3 Central & South America Human Somatotropin Market Facts & Figures 7
10 Middle East and Africa
10.1 Middle East and Africa Human Somatotropin by Country
10.1.1 Middle East and Africa Human Somatotropin Sales by Country
10.1.2 Middle East and Africa Human Somatotropin Revenue by Country
10.1.3 Turkey
10.1.4 GCC Countries
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Human Somatotropin Market Facts & Figures 2
10.3 Middle East and Africa Human Somatotropin Market Facts & Figures 7
11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Description, Business Overview and Total Revenue
11.1.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novo Nordisk Human Somatotropin Products Offered
11.1.5 Novo Nordisk Recent Development
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Description, Business Overview and Total Revenue
11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Pfizer Human Somatotropin Products Offered
11.2.5 Pfizer Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Corporation Information
11.3.2 Eli Lilly Description, Business Overview and Total Revenue
11.3.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Eli Lilly Human Somatotropin Products Offered
11.3.5 Eli Lilly Recent Development
11.4 Merck Serono
11.4.1 Merck Serono Corporation Information
11.4.2 Merck Serono Description, Business Overview and Total Revenue
11.4.3 Merck Serono Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck Serono Human Somatotropin Products Offered
11.4.5 Merck Serono Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Corporation Information
11.5.2 F. Hoffmann-La Roche Description, Business Overview and Total Revenue
11.5.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.5.4 F. Hoffmann-La Roche Human Somatotropin Products Offered
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Ferring Pharmaceuticals
11.6.1 Ferring Pharmaceuticals Corporation Information
11.6.2 Ferring Pharmaceuticals Description, Business Overview and Total Revenue
11.6.3 Ferring Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Ferring Pharmaceuticals Human Somatotropin Products Offered
11.6.5 Ferring Pharmaceuticals Recent Development
11.7 GeneScience Pharmaceuticals
11.7.1 GeneScience Pharmaceuticals Corporation Information
11.7.2 GeneScience Pharmaceuticals Description, Business Overview and Total Revenue
11.7.3 GeneScience Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.7.4 GeneScience Pharmaceuticals Human Somatotropin Products Offered
11.7.5 GeneScience Pharmaceuticals Recent Development
11.8 Ipsen
11.8.1 Ipsen Corporation Information
11.8.2 Ipsen Description, Business Overview and Total Revenue
11.8.3 Ipsen Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Ipsen Human Somatotropin Products Offered
11.8.5 Ipsen Recent Development
11.9 LG Life Sciences
11.9.1 LG Life Sciences Corporation Information
11.9.2 LG Life Sciences Description, Business Overview and Total Revenue
11.9.3 LG Life Sciences Sales, Revenue and Gross Margin (2015-2020)
11.9.4 LG Life Sciences Human Somatotropin Products Offered
11.9.5 LG Life Sciences Recent Development
11.10 Sandoz International
11.10.1 Sandoz International Corporation Information
11.10.2 Sandoz International Description, Business Overview and Total Revenue
11.10.3 Sandoz International Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Sandoz International Human Somatotropin Products Offered
11.10.5 Sandoz International Recent Development
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Description, Business Overview and Total Revenue
11.1.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novo Nordisk Human Somatotropin Products Offered
11.1.5 Novo Nordisk Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Human Somatotropin Market Estimates and Projections by Region
12.1.1 Global Human Somatotropin Sales Forecast by Regions 2021-2026
12.1.2 Global Human Somatotropin Revenue Forecast by Regions 2021-2026
12.2 North America Human Somatotropin Market Size Forecast (2021-2026)
12.2.1 North America: Human Somatotropin Sales Forecast (2021-2026)
12.2.2 North America: Human Somatotropin Revenue Forecast (2021-2026)
12.2.3 North America: Human Somatotropin Market Size Forecast by Country (2021-2026)
12.3 Europe Human Somatotropin Market Size Forecast (2021-2026)
12.3.1 Europe: Human Somatotropin Sales Forecast (2021-2026)
12.3.2 Europe: Human Somatotropin Revenue Forecast (2021-2026)
12.3.3 Europe: Human Somatotropin Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Human Somatotropin Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Human Somatotropin Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Human Somatotropin Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Human Somatotropin Market Size Forecast by Region (2021-2026)
12.5 Latin America Human Somatotropin Market Size Forecast (2021-2026)
12.5.1 Latin America: Human Somatotropin Sales Forecast (2021-2026)
12.5.2 Latin America: Human Somatotropin Revenue Forecast (2021-2026)
12.5.3 Latin America: Human Somatotropin Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Human Somatotropin Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Human Somatotropin Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Human Somatotropin Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Human Somatotropin Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Human Somatotropin Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Human Somatotropin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Tables
Table 1. Human Somatotropin Market Segments
Table 2. Ranking of Global Top Human Somatotropin Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Human Somatotropin Market Size Growth Rate 2 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Powder
Table 5. Major Manufacturers of Solvent
Table 6. COVID-19 Impact Global Market: (Four Human Somatotropin Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Human Somatotropin Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Human Somatotropin Players to Combat Covid-19 Impact
Table 11. Global Human Somatotropin Market Size Growth Rate 7 2020-2026 (MT)
Table 12. Global Human Somatotropin Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 13. Global Human Somatotropin Sales by Regions 2015-2020 (MT)
Table 14. Global Human Somatotropin Sales Market Share by Regions (2015-2020)
Table 15. Global Human Somatotropin Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Human Somatotropin Sales by Manufacturers (2015-2020) (MT)
Table 17. Global Human Somatotropin Sales Share by Manufacturers (2015-2020)
Table 18. Global Human Somatotropin Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Human Somatotropin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Somatotropin as of 2019)
Table 20. Human Somatotropin Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Human Somatotropin Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Human Somatotropin Price (2015-2020) (USD/MT)
Table 23. Human Somatotropin Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Human Somatotropin Product Type
Table 25. Date of International Manufacturers Enter into Human Somatotropin Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Human Somatotropin Sales 2 (2015-2020) (MT)
Table 28. Global Human Somatotropin Sales Share 2 (2015-2020)
Table 29. Global Human Somatotropin Revenue 2 (2015-2020) (US$ Million)
Table 30. Global Human Somatotropin Revenue Share 2 (2015-2020)
Table 31. Human Somatotropin Average Selling Price (ASP) 2 2015-2020 (USD/MT)
Table 32. Global Human Somatotropin Sales 7 (2015-2020) (MT)
Table 33. Global Human Somatotropin Sales Share 7 (2015-2020)
Table 34. North America Human Somatotropin Sales by Country (2015-2020) (MT)
Table 35. North America Human Somatotropin Sales Market Share by Country (2015-2020)
Table 36. North America Human Somatotropin Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Human Somatotropin Revenue Market Share by Country (2015-2020)
Table 38. North America Human Somatotropin Sales 2 (2015-2020) (MT)
Table 39. North America Human Somatotropin Sales Market Share 2 (2015-2020)
Table 40. North America Human Somatotropin Sales 7 (2015-2020) (MT)
Table 41. North America Human Somatotropin Sales Market Share 7 (2015-2020)
Table 42. Europe Human Somatotropin Sales by Country (2015-2020) (MT)
Table 43. Europe Human Somatotropin Sales Market Share by Country (2015-2020)
Table 44. Europe Human Somatotropin Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Human Somatotropin Revenue Market Share by Country (2015-2020)
Table 46. Europe Human Somatotropin Sales 2 (2015-2020) (MT)
Table 47. Europe Human Somatotropin Sales Market Share 2 (2015-2020)
Table 48. Europe Human Somatotropin Sales 7 (2015-2020) (MT)
Table 49. Europe Human Somatotropin Sales Market Share 7 (2015-2020)
Table 50. Asia Pacific Human Somatotropin Sales by Region (2015-2020) (MT)
Table 51. Asia Pacific Human Somatotropin Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Human Somatotropin Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Human Somatotropin Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Human Somatotropin Sales 2 (2015-2020) (MT)
Table 55. Asia Pacific Human Somatotropin Sales Market Share 2 (2015-2020)
Table 56. Asia Pacific Human Somatotropin Sales 7 (2015-2020) (MT)
Table 57. Asia Pacific Human Somatotropin Sales Market Share 7 (2015-2020)
Table 58. Latin America Human Somatotropin Sales by Country (2015-2020) (MT)
Table 59. Latin America Human Somatotropin Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Human Somatotropin Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Human Somatotropin Revenue Market Share by Country (2015-2020)
Table 62. Latin America Human Somatotropin Sales 2 (2015-2020) (MT)
Table 63. Latin America Human Somatotropin Sales Market Share 2 (2015-2020)
Table 64. Latin America Human Somatotropin Sales 7 (2015-2020) (MT)
Table 65. Latin America Human Somatotropin Sales Market Share 7 (2015-2020)
Table 66. Middle East and Africa Human Somatotropin Sales by Country (2015-2020) (MT)
Table 67. Middle East and Africa Human Somatotropin Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Human Somatotropin Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Human Somatotropin Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Human Somatotropin Sales 2 (2015-2020) (MT)
Table 71. Middle East and Africa Human Somatotropin Sales Market Share 2 (2015-2020)
Table 72. Middle East and Africa Human Somatotropin Sales 7 (2015-2020) (MT)
Table 73. Middle East and Africa Human Somatotropin Sales Market Share 7 (2015-2020)
Table 74. Novo Nordisk Corporation Information
Table 75. Novo Nordisk Description and Major Businesses
Table 76. Novo Nordisk Human Somatotropin Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Novo Nordisk Product
Table 78. Novo Nordisk Recent Development
Table 79. Pfizer Corporation Information
Table 80. Pfizer Description and Major Businesses
Table 81. Pfizer Human Somatotropin Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Pfizer Product
Table 83. Pfizer Recent Development
Table 84. Eli Lilly Corporation Information
Table 85. Eli Lilly Description and Major Businesses
Table 86. Eli Lilly Human Somatotropin Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Eli Lilly Product
Table 88. Eli Lilly Recent Development
Table 89. Merck Serono Corporation Information
Table 90. Merck Serono Description and Major Businesses
Table 91. Merck Serono Human Somatotropin Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Merck Serono Product
Table 93. Merck Serono Recent Development
Table 94. F. Hoffmann-La Roche Corporation Information
Table 95. F. Hoffmann-La Roche Description and Major Businesses
Table 96. F. Hoffmann-La Roche Human Somatotropin Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. F. Hoffmann-La Roche Product
Table 98. F. Hoffmann-La Roche Recent Development
Table 99. Ferring Pharmaceuticals Corporation Information
Table 100. Ferring Pharmaceuticals Description and Major Businesses
Table 101. Ferring Pharmaceuticals Human Somatotropin Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Ferring Pharmaceuticals Product
Table 103. Ferring Pharmaceuticals Recent Development
Table 104. GeneScience Pharmaceuticals Corporation Information
Table 105. GeneScience Pharmaceuticals Description and Major Businesses
Table 106. GeneScience Pharmaceuticals Human Somatotropin Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. GeneScience Pharmaceuticals Product
Table 108. GeneScience Pharmaceuticals Recent Development
Table 109. Ipsen Corporation Information
Table 110. Ipsen Description and Major Businesses
Table 111. Ipsen Human Somatotropin Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Ipsen Product
Table 113. Ipsen Recent Development
Table 114. LG Life Sciences Corporation Information
Table 115. LG Life Sciences Description and Major Businesses
Table 116. LG Life Sciences Human Somatotropin Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. LG Life Sciences Product
Table 118. LG Life Sciences Recent Development
Table 119. Sandoz International Corporation Information
Table 120. Sandoz International Description and Major Businesses
Table 121. Sandoz International Human Somatotropin Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Sandoz International Product
Table 123. Sandoz International Recent Development
Table 124. Anhui Anke Biotechnology Corporation Information
Table 125. Anhui Anke Biotechnology Description and Major Businesses
Table 126. Anhui Anke Biotechnology Human Somatotropin Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 127. Anhui Anke Biotechnology Product
Table 128. Anhui Anke Biotechnology Recent Development
Table 129. Global Human Somatotropin Sales Forecast by Regions (2021-2026) (MT)
Table 130. Global Human Somatotropin Sales Market Share Forecast by Regions (2021-2026)
Table 131. Global Human Somatotropin Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 132. Global Human Somatotropin Revenue Market Share Forecast by Regions (2021-2026)
Table 133. North America: Human Somatotropin Sales Forecast by Country (2021-2026) (MT)
Table 134. North America: Human Somatotropin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 135. Europe: Human Somatotropin Sales Forecast by Country (2021-2026) (MT)
Table 136. Europe: Human Somatotropin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Asia Pacific: Human Somatotropin Sales Forecast by Region (2021-2026) (MT)
Table 138. Asia Pacific: Human Somatotropin Revenue Forecast by Region (2021-2026) (US$ Million)
Table 139. Latin America: Human Somatotropin Sales Forecast by Country (2021-2026) (MT)
Table 140. Latin America: Human Somatotropin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Middle East and Africa: Human Somatotropin Sales Forecast by Country (2021-2026) (MT)
Table 142. Middle East and Africa: Human Somatotropin Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 144. Key Challenges
Table 145. Market Risks
Table 146. Main Points Interviewed from Key Human Somatotropin Players
Table 147. Human Somatotropin Customers List
Table 148. Human Somatotropin Distributors List
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Somatotropin Product Picture
Figure 2. Global Human Somatotropin Sales Market Share 2 in 2020 & 2026
Figure 3. Powder Product Picture
Figure 4. Solvent Product Picture
Figure 5. Global Human Somatotropin Sales Market Share 7 in 2020 & 2026
Figure 6. Growth Hormone Deficiency (GHD)
Figure 7. Turner Syndrome
Figure 8. Chronic Renal Insufficiency
Figure 9. Prader Willi Syndrome
Figure 10. Small for Gestational Age
Figure 11. SHOX Deficiency
Figure 12. Others
Figure 13. Human Somatotropin Report Years Considered
Figure 14. Global Human Somatotropin Market Size 2015-2026 (US$ Million)
Figure 15. Global Human Somatotropin Sales 2015-2026 (MT)
Figure 16. Global Human Somatotropin Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Human Somatotropin Sales Market Share by Region (2015-2020)
Figure 18. Global Human Somatotropin Sales Market Share by Region in 2019
Figure 19. Global Human Somatotropin Revenue Market Share by Region (2015-2020)
Figure 20. Global Human Somatotropin Revenue Market Share by Region in 2019
Figure 21. Global Human Somatotropin Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Human Somatotropin Revenue in 2019
Figure 23. Human Somatotropin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Human Somatotropin Sales Market Share 2 (2015-2020)
Figure 25. Global Human Somatotropin Sales Market Share 2 in 2019
Figure 26. Global Human Somatotropin Revenue Market Share 2 (2015-2020)
Figure 27. Global Human Somatotropin Revenue Market Share 2 in 2019
Figure 28. Global Human Somatotropin Market Share by Price Range (2015-2020)
Figure 29. Global Human Somatotropin Sales Market Share 7 (2015-2020)
Figure 30. Global Human Somatotropin Sales Market Share 7 in 2019
Figure 31. Global Human Somatotropin Revenue Market Share 7 (2015-2020)
Figure 32. Global Human Somatotropin Revenue Market Share 7 in 2019
Figure 33. North America Human Somatotropin Sales Growth Rate 2015-2020 (MT)
Figure 34. North America Human Somatotropin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Human Somatotropin Sales Market Share by Country in 2019
Figure 36. North America Human Somatotropin Revenue Market Share by Country in 2019
Figure 37. United States Human Somatotropin Sales Growth Rate (2015-2020) (MT)
Figure 38. United States Human Somatotropin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Human Somatotropin Sales Growth Rate (2015-2020) (MT)
Figure 40. Canada Human Somatotropin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Mexico Human Somatotropin Sales Growth Rate (2015-2020) (MT)
Figure 42. Mexico Human Somatotropin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. North America Human Somatotropin Market Share 2 in 2019
Figure 44. North America Human Somatotropin Market Share 7 in 2019
Figure 45. Europe Human Somatotropin Sales Growth Rate 2015-2020 (MT)
Figure 46. Europe Human Somatotropin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Human Somatotropin Sales Market Share by Country in 2019
Figure 48. Europe Human Somatotropin Revenue Market Share by Country in 2019
Figure 49. Germany Human Somatotropin Sales Growth Rate (2015-2020) (MT)
Figure 50. Germany Human Somatotropin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Human Somatotropin Sales Growth Rate (2015-2020) (MT)
Figure 52. France Human Somatotropin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. UK Human Somatotropin Sales Growth Rate (2015-2020) (MT)
Figure 54. UK Human Somatotropin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Human Somatotropin Sales Growth Rate (2015-2020) (MT)
Figure 56. Italy Human Somatotropin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Human Somatotropin Sales Growth Rate (2015-2020) (MT)
Figure 58. Russia Human Somatotropin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Europe Human Somatotropin Market Share 2 in 2019
Figure 60. Europe Human Somatotropin Market Share 7 in 2019
Figure 61. Asia Pacific Human Somatotropin Sales Growth Rate 2015-2020 (MT)
Figure 62. Asia Pacific Human Somatotropin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific Human Somatotropin Sales Market Share by Region in 2019
Figure 64. Asia Pacific Human Somatotropin Revenue Market Share by Region in 2019
Figure 65. China Human Somatotropin Sales Growth Rate (2015-2020) (MT)
Figure 66. China Human Somatotropin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan Human Somatotropin Sales Growth Rate (2015-2020) (MT)
Figure 68. Japan Human Somatotropin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea Human Somatotropin Sales Growth Rate (2015-2020) (MT)
Figure 70. South Korea Human Somatotropin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India Human Somatotropin Sales Growth Rate (2015-2020) (MT)
Figure 72. India Human Somatotropin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia Human Somatotropin Sales Growth Rate (2015-2020) (MT)
Figure 74. Australia Human Somatotropin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Human Somatotropin Sales Growth Rate (2015-2020) (MT)
Figure 76. Indonesia Human Somatotropin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Human Somatotropin Sales Growth Rate (2015-2020) (MT)
Figure 78. Thailand Human Somatotropin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Human Somatotropin Sales Growth Rate (2015-2020) (MT)
Figure 80. Malaysia Human Somatotropin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Human Somatotropin Sales Growth Rate (2015-2020) (MT)
Figure 82. Philippines Human Somatotropin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Human Somatotropin Sales Growth Rate (2015-2020) (MT)
Figure 84. Vietnam Human Somatotropin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Human Somatotropin Market Share 2 in 2019
Figure 86. Asia Pacific Human Somatotropin Market Share 7 in 2019
Figure 87. Latin America Human Somatotropin Sales Growth Rate 2015-2020 (MT)
Figure 88. Latin America Human Somatotropin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Human Somatotropin Sales Market Share by Country in 2019
Figure 90. Latin America Human Somatotropin Revenue Market Share by Country in 2019
Figure 91. Brazil Human Somatotropin Sales Growth Rate (2015-2020) (MT)
Figure 92. Brazil Human Somatotropin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Human Somatotropin Market Share 2 in 2019
Figure 94. Latin America Human Somatotropin Market Share 7 in 2019
Figure 95. Middle East and Africa Human Somatotropin Sales Growth Rate 2015-2020 (MT)
Figure 96. Middle East and Africa Human Somatotropin Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Human Somatotropin Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Human Somatotropin Revenue Market Share by Country in 2019
Figure 99. Turkey Human Somatotropin Sales Growth Rate (2015-2020) (MT)
Figure 100. Turkey Human Somatotropin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. GCC Countries Human Somatotropin Sales Growth Rate (2015-2020) (MT)
Figure 102. GCC Countries Human Somatotropin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Egypt Human Somatotropin Sales Growth Rate (2015-2020) (MT)
Figure 104. Egypt Human Somatotropin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. South Africa Human Somatotropin Sales Growth Rate (2015-2020) (MT)
Figure 106. South Africa Human Somatotropin Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Human Somatotropin Market Share 2 in 2019
Figure 108. Middle East and Africa Human Somatotropin Market Share 7 in 2019
Figure 109. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Merck Serono Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. F. Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Ferring Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. GeneScience Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Ipsen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. LG Life Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Sandoz International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. Anhui Anke Biotechnology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. North America Human Somatotropin Sales Growth Rate Forecast (2021-2026) (MT)
Figure 121. North America Human Somatotropin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Europe Human Somatotropin Sales Growth Rate Forecast (2021-2026) (MT)
Figure 123. Europe Human Somatotropin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Asia Pacific Human Somatotropin Sales Growth Rate Forecast (2021-2026) (MT)
Figure 125. Asia Pacific Human Somatotropin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Latin America Human Somatotropin Sales Growth Rate Forecast (2021-2026) (MT)
Figure 127. Latin America Human Somatotropin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 128. Middle East and Africa Human Somatotropin Sales Growth Rate Forecast (2021-2026) (MT)
Figure 129. Middle East and Africa Human Somatotropin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 130. Porter's Five Forces Analysis
Figure 131. Channels of Distribution
Figure 132. Distributors Profiles
Figure 133. Bottom-up and Top-down Approaches for This Report
  • Outlook of Diabetic Macular Edema – Current Landscape and the Way Forward
    Published: 08-Jul-2020        Price: US 4500 Onwards        Pages: 81
    Global market for DME was ~$3.7 billion in 2019 with US alone contributing to 51% market share, owing to the higher incidence rates of diabetes amongst the developed nations. In 2018, ~2.4m people in the US had DME, of that only ~70% got diagnosed and treated. Following is the current treatment paradigm for DME - the first line includes Eylea (Regeneron), Lucentis (Roche/Genentech) and the second line treatment includes short term steroids implants such as dexamethasone (Ozurdex, Allergen; on......
  • 2014-2029 Report on Global Therapeutic Nuclear Medicines Market by Player, Region, Type, Application and Sales Channel
    Published: 08-Jul-2020        Price: US 2500 Onwards        Pages: 115
    The global Therapeutic Nuclear Medicines market was valued at $XX million in 2017, and MAResearch analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2017 and 2029. Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 210 countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly affect......
  • 2014-2029 Report on Global Infertility Drugs Market by Player, Region, Type, Application and Sales Channel
    Published: 08-Jul-2020        Price: US 2500 Onwards        Pages: 104
    The global Infertility Drugs market was valued at $XX million in 2019, and MAResearch analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2019 and 2029. Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 210 countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly affect this indust......
  • 2014-2029 Report on Global Hyaluronic Acid (Sodium +Injection) Market by Player, Region, Type, Application and Sales Channel
    Published: 08-Jul-2020        Price: US 2500 Onwards        Pages: 100
    The global Hyaluronic Acid (Sodium +Injection) market was valued at $XX million in 2019, and MAResearch analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2019 and 2029. Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 210 countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly ......
  • 2014-2029 Report on Global Chondroitin Market by Player, Region, Type, Application and Sales Channel
    Published: 08-Jul-2020        Price: US 2500 Onwards        Pages: 117
    The global Chondroitin market was valued at $XX million in 2019, and MAResearch analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2019 and 2029. Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 210 countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly affect this industry in ......
  • 2014-2029 Report on Global Anti-infective Ophthalmic Market by Player, Region, Type, Application and Sales Channel
    Published: 08-Jul-2020        Price: US 2500 Onwards        Pages: 106
    The global Anti-infective Ophthalmic market was valued at $XX million in 2019, and MAResearch analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2019 and 2029. Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 210 countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly affect thi......
  • 2014-2029 Report on Global Inulin Market by Player, Region, Type, Application and Sales Channel
    Published: 08-Jul-2020        Price: US 2500 Onwards        Pages: 116
    The global Inulin market was valued at $XX million in 2019, and MAResearch analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2019 and 2029. Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 210 countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly affect this industry in 2020.......
  • 2014-2029 Report on Global Renal Cell Carcinoma Drugs Market by Player, Region, Type, Application and Sales Channel
    Published: 08-Jul-2020        Price: US 2500 Onwards        Pages: 108
    The global Renal Cell Carcinoma Drugs market was valued at $XX million in 2019, and MAResearch analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2019 and 2029. Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 210 countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly affect th......
  • 2014-2029 Report on Global Anti-tumor Drug Market by Player, Region, Type, Application and Sales Channel
    Published: 08-Jul-2020        Price: US 2500 Onwards        Pages: 119
    The global Anti-tumor Drug market was valued at $XX million in 2019, and MAResearch analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2019 and 2029. Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 210 countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly affect this industry......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs